On the Association between Human Papillomavirus Vaccine and Primary Ovarian Failure
2013; Wiley; Volume: 71; Issue: 4 Linguagem: Inglês
10.1111/aji.12190
ISSN1600-0897
AutoresPaolo Pellegrino, Carla Carnovale, Valentina Perrone, Dionigi Salvati, Marta Gentili, Tatiana Brusadelli, Marco Pozzi, Stefania Antoniazzi, Emilio Clementi, Sonia Radice,
Tópico(s)Ovarian cancer diagnosis and treatment
ResumoAmerican Journal of Reproductive ImmunologyVolume 71, Issue 4 p. 293-294 Letter to the Editor On the Association between Human Papillomavirus Vaccine and Primary Ovarian Failure Paolo Pellegrino, Paolo Pellegrino Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalyThese authors contributed equally to this work.Search for more papers by this authorCarla Carnovale, Carla Carnovale Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalyThese authors contributed equally to this work.Search for more papers by this authorValentina Perrone, Valentina Perrone Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorDionigi Salvati, Dionigi Salvati Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorMarta Gentili, Marta Gentili Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorTatiana Brusadelli, Tatiana Brusadelli Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorMarco Pozzi, Marco Pozzi Scientific Institute, IRCCS E. Medea, Lecco, ItalySearch for more papers by this authorStefania Antoniazzi, Stefania Antoniazzi IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, ItalySearch for more papers by this authorEmilio Clementi, Corresponding Author Emilio Clementi Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, Italy Scientific Institute, IRCCS E. Medea, Lecco, Italy Correspondence Emilio Clementi, Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, 20157 Milan, Italy. E-mail: [email protected]Search for more papers by this authorSonia Radice, Sonia Radice Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this author Paolo Pellegrino, Paolo Pellegrino Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalyThese authors contributed equally to this work.Search for more papers by this authorCarla Carnovale, Carla Carnovale Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalyThese authors contributed equally to this work.Search for more papers by this authorValentina Perrone, Valentina Perrone Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorDionigi Salvati, Dionigi Salvati Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorMarta Gentili, Marta Gentili Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorTatiana Brusadelli, Tatiana Brusadelli Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this authorMarco Pozzi, Marco Pozzi Scientific Institute, IRCCS E. Medea, Lecco, ItalySearch for more papers by this authorStefania Antoniazzi, Stefania Antoniazzi IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, ItalySearch for more papers by this authorEmilio Clementi, Corresponding Author Emilio Clementi Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, Italy Scientific Institute, IRCCS E. Medea, Lecco, Italy Correspondence Emilio Clementi, Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, 20157 Milan, Italy. E-mail: [email protected]Search for more papers by this authorSonia Radice, Sonia Radice Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, Milan, ItalySearch for more papers by this author First published: 23 December 2013 https://doi.org/10.1111/aji.12190Citations: 22 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y: Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol 2013; 70: 309–316. 2Little DT, Ward HR: Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination. BMJ Case Rep 2012; 2012. doi: 10.1136/bcr-2012-006879. 3Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB: Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J 2007; 26: 979–984. 4Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, Radice S: Can HPV immunisation cause ADEM? Two case reports and literature review. Mult Scler 2013 [Epub ahead of print]. 5http://vaers.hhs.gov/index [last accessed 10/21/13] 6http://www.tga.gov.au/DAEN/daen-entry.aspx [last accessed 10/21/13] 7http://www.adrreports.eu/EN/search.html# [last accessed 10/21/13] 8http://hcupnet.ahrq.gov/HCUPnet.jsp [last accessed 10/21/13] Citing Literature Volume71, Issue4April 2014Pages 293-294 ReferencesRelatedInformation
Referência(s)